Dr. Yariv Houvras, MD

Dr. Yariv Houvras, MD

Save
Medical Oncology  ·  
Male  ·  
48 y/o

Accepting new patients

Dr. Yariv Houvras, MD is a medical oncology specialist in New York, NY and has been practicing for 10 years. He specializes in medical oncology, hematology, and more.Read his story

Solid Tumor/GI Oncology Practice

1305 York Ave Fl 12

New York, NY 10021
Get Directions

Insurance Accepted

  • Aetna
  • Blue Cross Blue Shield
  • Cigna
  • EmblemHealth
  • Empire Blue Cross Blue Shield
  • Humana
  • Oxford Health Plans
  • UnitedHealthCare

Learn about Dr. Houvras

Be confident in your decisions by checking out your provider's top areas of care, education, patient reviews and more. Learn about finding the right doctor for you.

Video

Top Care Areas

See how frequently Dr. Houvras performs your care needs compared to other doctors.

Thyroid Cancer
normal
more than 67% of peers
Cancer
normal
more than 34% of peers

Dr. Houvras's percentages are based on the rate of treatment compared to peers nationwide from insurance data. Learn more info about our data and this Top Care Areas component.

Dr. Houvras' bio

This content was provided by Dr. Houvras "Dr. Yariv Houvras is an internationally-renowned expert in the treatment and care of patients with advanced thyroid cancers, including differentiated thyroid cancer, papillary and follicular cancers, poorly differentiated, anaplastic and medullary thyroid cancers. Dr. Houvras is a physician-scientist with an active laboratory program to explore the genetic basis of tumor initiation and progression. Dr. Houvras leads a laboratory program utilizing zebrafish, a small freshwater fish, amenable to genetic studies. Work in the Houvras lab has led to new personalized models of cancer. These models are being tested to identify new treatments for patients with cancer. The zebrafish are also being used in drug discovery efforts to identify new inhibitors of cancer growth and metastasis. Dr. Houvras was recruited to Weill Cornell Medical College in 2011 and has served as Assistant Professor of Medicine in the Departments of Surgery and Medicine. He is a member of the Meyer Cancer Center and Cancer Genetics and Epigenetics Working Group. Dr. Houvras is the recipient of numerous awards and grants, including a K08 mentored physician-scientist award, an R21 from the NIH, and a tri-institutional drug discovery award to develop novel epigenetic inhibitors for cancer. He also serves on the board of the International Thyroid Oncology Group (ITOG), an interdisciplinary organization that coordinates clinical trials and translational studies in thyroid cancer.Dr. Houvras is a graduate of the University of Michigan (B.S. in Biology, 1992) and the MSTP program at Mount Sinai School of Medicine where he earned a combined MD/PhD degree (2001). Dr. Houvras was an intern and resident at Massachusetts General Hospital (MGH), and a fellow in Hematology-Oncology at the combined Dana-Farber/MGH program. He completed post-doctoral studies in cancer genetics at Boston Children's Hospital. He was recruited to Weill Cornell Medicine and NewYork-Presbyterian Hospital in 2011."
Less
Read Less

Care Philosophy

This content was provided by Dr. Houvras "I am a physician-scientist with a clinical focus on treating patients with advanced thyroid cancers. I completed training in Hematology and Medical Oncology at Dana Farber Cancer Institute and joined the faculty at Weill Cornell Medical College in 2011. To advance the care of patients with thyroid cancer around the world, I have been actively involved in an international cooperative thyroid cancer oncology group (ITOG). Additionally, I have participated in clinical trials for tyrosine kinase inhibitor (TKI) therapy for patients with advanced thyroid cancer. I am dedicated to cancer research in order to lead us one step closer to a cure. I am particularly interested in cancer genetics in order to identify personalized therapies to fight cancer based on the genetic profiles of an individual's tumors. I also lead a cancer genetics lab at Weill Cornell where we use a model organism, zebrafish, to identify new drugs and drug targets."
Less
Read Less

3  Specialties

  • Medical Oncology
  • Hematology
  • Internal Medicine

3  Board Certifications

  • Hematology
    Accredited by: American Board of Internal Medicine*
  • Internal Medicine
    Accredited by: American Board of Internal Medicine*
  • Medical Oncology
    Accredited by: American Board of Internal Medicine*

18  Conditions Treated

Background Check

0 Malpractice Claims

No malpractice history found for New York.

0 Sanctions

No sanctions history found for the years that Healthgrades collects data.

0 Board Actions

No board actions found for the years that Healthgrades collects data.

Education

  • Mount Sinai School Of Medicine
    Medical School | Graduated 2001
  • Massachusetts General Hospital
    Internship Hospital | Completed 2002
  • Massachusetts General Hospital
    Residency Hospital | Completed 2003
  • Dana Farber Canc Institute
    Fellowship Hospital | Completed 2008

Awards & Recognition

Awards & Honors
  • Healthgrades Honor Roll
Media & Publications

Dr. Houvras has no media or publications listed.

Languages Spoken

  • English

Memberships & Professional Affiliations

Dr. Houvras does not have any memberships or affiliations listed. If you are Dr. Houvras and would like to add memberships or affiliations, please update your profile.

Dr. Houvras' Reviews

Help millions of people find the right doctor. Share your experience today!
Likelihood of recommending Dr. Houvras to family and friends
Image of Dr. Houvras
Are you Dr. Houvras?
Make it easy for patients to share their feedback. Also manage your personalized profile!